Publisher
Springer International Publishing
Reference151 articles.
1. Al Yaghchi C, Zhang Z, Alusi G et al (2015) Vaccinia virus, a promising new therapeutic agent for pancreatic cancer. Immunotherapy 7:1249–1258
2. Apostolidis L, Schirrmacher V, Fournier P (2007) Host mediated anti-tumor effect of oncolytic Newcastle disease virus after locoregional application. Int J Oncol 31:1009–1019
3. Armstrong CA, Botella R, Galloway TH et al (1996) Antitumor effects of granulocyte-macrophage colony-stimulating factor production by melanoma cells. Cancer Res 56:2191–2198
4. Atkins MB, Lotze MT, Dutcher JP et al (1999) High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993. J Clin Oncol 17:2105–2116
5. Bai F, Niu Z, Tian H et al (2014) Genetically engineered Newcastle disease virus expressing interleukin2 is a potential drug candidate for cancer immunotherapy. Immunol Lett 159:36–46